Bristol-Myers Squibb
BMY
#190
Rank
NZ$186.36 B
Marketcap
NZ$91.55
Share price
1.42%
Change (1 day)
-12.90%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): NZ$5.12

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is NZ$4.94. In 2024 the company made an earnings per share (EPS) of NZ-$7.35 a decrease over its 2023 EPS that were of NZ$6.45.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$5.12-169.64%
2024NZ-$7.35-213.92%
2023NZ$6.4530.2%
2022NZ$4.96-6.04%
2021NZ$5.27-179.29%
2020NZ-$6.65-281.37%
2019NZ$3.67-27.21%
2018NZ$5.04
2016NZ$4.44175.26%
2015NZ$1.61-19.83%
2014NZ$2.01-22.44%
2013NZ$2.5934.48%
2012NZ$1.93

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$17.36 251.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.24 147.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.86-42.09%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$2.25-54.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$34.12 590.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$21.67 338.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$6.16 24.77%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$18.28 270.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.63 155.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$5.05 2.19%๐Ÿ‡ฌ๐Ÿ‡ง UK